Coronary mortality declines in the U.S. between 1980 and 2000 quantifying the contributions from primary and

Fiona Young1, Simon Capewell, Earl S Ford

  • 1Institute of Health and Society, Newcastle University, Newcastle Upon Tyne, United Kingdom. Fiona.young@ncl.ac.uk

Insights

Primary prevention efforts significantly reduced coronary heart disease deaths by 79% between 1980 and 2000. Risk factor declines in asymptomatic individuals drove most of this substantial mortality reduction.

Area of Science:

  • Cardiovascular Disease Epidemiology
  • Public Health Interventions
  • Preventive Medicine

Background:

  • Coronary heart disease (CHD) mortality has decreased significantly in the U.S. since 1980, but remains a leading cause of death.
  • The relative impact of primary versus secondary prevention on this mortality decline is debated.
  • Understanding these contributions is crucial for future public health strategies.

Purpose of the Study:

  • To quantify the specific contributions of primary and secondary prevention to the U.S. CHD mortality decline from 1980 to 2000.
  • To differentiate the impact of risk factor reductions in asymptomatic individuals versus those with existing CHD.
  • To inform the allocation of resources for cardiovascular disease prevention.

Main Methods:

  • Utilized the IMPACT model to estimate mortality reductions attributed to risk factor declines.
  • Differentiated between risk factor changes in asymptomatic individuals (primary prevention) and CHD patients (secondary prevention).
  • Analyses were conducted in 2008 to assess the period 1980-2000.

Main Results:

  • Risk factor declines accounted for approximately 316,100 fewer CHD deaths.
  • Primary prevention (asymptomatic individuals) contributed 79% (251,170 deaths), while secondary prevention (CHD patients) contributed 21% (64,930 deaths).
  • Key factors included cholesterol reduction, blood pressure control, smoking cessation, and statin/antihypertensive medication use.

Conclusions:

  • Risk factor declines were responsible for half of the U.S. CHD mortality reduction between 1980 and 2000.
  • Primary prevention strategies yielded substantially greater mortality reductions than secondary prevention.
  • Public health initiatives targeting risk factors in the general population are highly effective.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
Levels of Health Promotion and Illness Prevention01:26

Levels of Health Promotion and Illness Prevention

Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...